Brief: Sonoma Pharmaceuticals And Crown Laboratories Announce An Exclusive Partnership To Launch Microcyn® Technology-Based Anti-Itch Over-The-Counter Products
10/12/2020 21:38
Sonoma Pharmaceuticals Inc SNOA.O :
* SONOMA PHARMACEUTICALS AND CROWN LABORATORIES ANNOUNCE AN
EXCLUSIVE PARTNERSHIP TO LAUNCH MICROCYN® TECHNOLOGY-BASED
ANTI-ITCH OVER-THE-COUNTER PRODUCTS
Source text for Eikon: ID:nBw7gTPKVa
Further company coverage: SNOA.O
Recent news on Sonoma Pharmaceuticals
See all newsSonoma Pharmaceuticals Q1 revenue rises on US growth
Brief: Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million
Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth
Brief: Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand
Brief: Sonoma Pharmaceuticals Inc - Offers Units In Public Offering For Gross Proceeds Of $5 Million - SEC Filing